12:00 AM
Jul 29, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Tecfidera dimethyl fumarate: Postmarketing study data

Biogen Idec said a 59-year old female MS patient died due to bilateral pneumonia 2.5 weeks after discontinuing treatment with Tecfidera, but the company said "a link to Tecfidera is unlikely" based on the circumstances of the case and cause of death. The biotech said...

Read the full 205 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >